Volume, not price, to drive growth in EU artificial spinal disc market
This article was originally published in Clinica
Sales of artificial spinal discs will be the biggest growth driver of the European* market for non-fusion, motion-preserving spinal devices over the next few years. However, makers of these artificial discs – Medtronic and Johnson & Johnson being among the biggest players in this sector – are likely to face ongoing headwinds in terms of pricing pressures.
You may also be interested in...
Minimally invasive glaucoma surgery specialist Glaukos saw its stock leap 40% in the wake of a worldwide recall by much bigger rival Alcon of its CyPass microstent.
Roland Diggelmann will end his decade-long career at Roche Diagnostics at the end of September. The business's head of EMEA Michael Heuer will take Diggelmann's place while the search is on for his replacement.
Philips has added a new pulse oximetry platform to its patient monitoring portfolio, with the acquisition of Xhale Assurance.